Webinar | September 25, 2025

Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency

Biopharmaceutical manufacturers are under growing pressure to deliver safe, effective therapies with greater speed and efficiency, making small-scale downstream process studies an essential strategy for advancing biologics manufacturing. By replicating full-scale conditions in a controlled laboratory setting, these studies provide critical insights that help mitigate risk, refine control strategies, and generate robust data — ultimately streamlining technology transfer, strengthening process validation, and supporting regulatory compliance.

In this webinar, our experts will showcase how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities. Through real-world case studies, you will gain a clear understanding of how these methods drive higher product quality, enable faster regulatory approvals, and bring therapies to patients more efficiently.

Key takeaways include how small-scale studies enable seamless tech transfer, their pivotal role in process validation and regulatory alignment, and how applying study data can optimize processes, improve outcomes, and shorten time to market.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online